Orphan drug approvals in neurology could triple

"Among the remaining designations I found interesting 4 treatments for #ataxias " - Ana Mingorance @CNSdrughunter


(I am very PROUD to know Ana and we have met on numerous occasions)

Interesting Article
via a good friend Ana

(As usual, the pharma industry is complicated !)

The link failed, so I googled​:wink: I’ve never heard of Dravet’s Syndrome. So MANY rare conditions :smirk:xB